Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

New Market Study Published: Actelion Ltd - Product Pipeline Review - 2013


Print article Print article
2014-01-27 10:49:55 - Fast Market Research recommends "Actelion Ltd - Product Pipeline Review - 2013" from Global Markets Direct, now available

Global Market Direct's pharmaceuticals report, "Actelion Ltd - Product Pipeline Review - 2013" provides data on the Actelion Ltd's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Actelion Ltd's corporate website, SEC filings, investor presentations and featured press releases, both from Actelion Ltd and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Actelion Ltd - Brief Actelion Ltd overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Actelion Ltd human therapeutic division.
* Overview of pipeline therapeutics

across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Actelion Ltd with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Actelion Ltd's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Full Report Details at
- www.fastmr.com/prod/769241_actelion_ltd_product_pipeline_review_ ..

Reasons to Get this Report

* Evaluate Actelion Ltd's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Actelion Ltd in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Actelion Ltd's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Actelion Ltd.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Actelion Ltd and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Actelion Ltd Snapshot
Actelion Ltd Overview
Key Information
Key Facts
Actelion Ltd - Research and Development Overview
Key Therapeutic Areas
Actelion Ltd - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Actelion Ltd - Pipeline Products Glance
Actelion Ltd - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Filing rejected/Withdrawn Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Actelion Ltd - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Actelion Ltd - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Actelion Ltd - Unknown Stage Pipeline Products
Unknown Products/Combination Treatment Modalities
Actelion Ltd - Drug Profiles
macitentan
Product Description
Mechanism of Action
R&D Progress
tesamorelin acetate
Product Description
Mechanism of Action
R&D Progress
bosentan
Product Description
Mechanism of Action
R&D Progress
cadazolid
Product Description
Mechanism of Action
R&D Progress
selexipag
Product Description
Mechanism of Action
R&D Progress
ACT-280778
Product Description
Mechanism of Action
R&D Progress
ponesimod
Product Description
Mechanism of Action
R&D Progress
ACT-246475
Product Description
Mechanism of Action
R&D Progress
ACT-281959
Product Description
Mechanism of Action
R&D Progress
ACT-434964
Product Description
Mechanism of Action
R&D Progress
ACT-462206
Product Description
Mechanism of Action
R&D Progress
CRTH-2 Receptor Antagonist
Product Description
Mechanism of Action
R&D Progress
Drug For Cardiovascular Disorders
Product Description
Mechanism of Action
R&D Progress
Drug For Immunological Disorders
Product Description
Mechanism of Action
R&D Progress
Drug For Malaria
Product Description
Mechanism of Action
R&D Progress
lucerastat
Product Description
Mechanism of Action
R&D Progress
Orexin Receptor Antagonist
Product Description
Mechanism of Action
R&D Progress
S1P1 Receptor Agonist
Product Description
Mechanism of Action
R&D Progress
Compound-49e
Product Description
Mechanism of Action
R&D Progress
DNA Ligase Inhibitors
Product Description
Mechanism of Action
R&D Progress
Compound-49c
Product Description
Mechanism of Action
R&D Progress
Dual Orexin Receptor Antagonists
Product Description
Mechanism of Action
R&D Progress
Drug for cancer
Product Description
Mechanism of Action
R&D Progress
Actelion Ltd - Pipeline Analysis
Actelion Ltd - Pipeline Products by Therapeutic Class
Actelion Ltd - Pipeline Products by Target

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=769241&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser